content_image/196246.jpg content_image/196247.jpg content_image/196248.jpg content_image/196249.jpg content_image/196250.jpg
## 2. Financial Assets 

The Company’s investment in its subsidiaries is as follows: 

<img src='content_image/196246.jpg'>

The equivalent disclosure for the prior year is as follows: 

<img src='content_image/196247.jpg'>

(i) The Company’s investment in shares in its subsidiaries was revalued at 31 December 1980 to reflect the surplus on revaluation of certain property, plant and equipment (land and buildings) of subsidiaries. The original historical cost of the shares equated to approximately €9 million. The analysis of the closing balance between amounts carried at valuation and at cost is as follows: 

<img src='content_image/196248.jpg'>

Pursuant to Section 16 of the Companies (Amendment) Act, 1986, a full list of subsidiaries, joint ventures and associated undertakings will be annexed to the Company’s Annual Return to be filed in the Companies Registration Office in Ireland. 

## 3. Debtors 

<img src='content_image/196249.jpg'>

## 4. Trade and Other Creditors 

<img src='content_image/196250.jpg'>

## 5. Auditor’s Remuneration (Memorandum Disclosure) 

In accordance with section 161D of the Companies Act, 1963, the fees paid in 2012 to the statutory auditor for work engaged by the parent company comprised audit fees of €20,000 (2011: €20,000) and other assurance services of €108,000 (2011: €247,000). 

## 6. Dividends Proposed (Memorandum Disclosure) 

Details in respect of dividends proposed of €320 million (2011: €316 million) are presented in the dividends note (note 12) on page 92 of the notes to the Consolidated Financial Statements. 

## 7. Called-up Share Capital 

Details in respect of called-up share capital, Treasury Shares and own shares are presented in the share capital and reserves note (note 29) on pages 113 and 114 of the notes to the Consolidated Financial Statements. 

